MedPath

Strain Imaging in Patients With Functional Mitral Regurgitation, Treated With MitraClip

Completed
Conditions
Heart Failure
Mitral Regurgitation
Interventions
Diagnostic Test: speckle tracking analysis of transthoracic echocardiogram
Registration Number
NCT04218578
Lead Sponsor
University of Athens
Brief Summary

The aim of this study is i) to evaluate left ventricular global longitudinal strain and myocardial work in patients with heart failure and severe functional mitral regurgitation one year after MitraClip implantation and compare these variables with patients treated with optimal medical treatment and ii) to find echocardiographic predictors of clinical response and reverse left ventricular remodeling at one-year follow up.

Detailed Description

This study is one of the first in terms of publication. As far as the investigators know there are few papers with small series of patients regarding echocardiographic parameters and strain imaging in patients with functional mitral regurgitation (MR) and MitraClip. As the investigator's goal is to assess the potential impact of the MitraClip on myocardial deformation indexes, at the end of the study a direct comparison of changes of echocardiography markers -at one year follow up- between the control and device group will be performed. The changes in myocardial deformation markers will be associated with the respective changes in Brain-natriuretic peptide (BNP) levels, New York Heart Association (NYHA) class status, 6-minute walking distance (6MWD) and left ventricle (LV) volumes at follow -up. The investigators also aim to identify baseline prognostic echocardiography markers for the prediction of clinical improvement and LV reverse remodeling after successful edge-to-edge repair in functional MR patients during one year follow up. In specific, in this study the investigators will measure the 2-Dimension (2D) strain values of the left ventricle and left atrium (global longitudinal strain-GLS of the LV and Peak Atrial longitudinal strain - PALS of the left atrium) at baseline and at one year follow up, they will appreciate the LV myocardial work and all its components (Global Work Index-GWI, Global Constructed Work-GCW,Global wasted work-GWW and Global Work Efficiency-GWE) of the left ventricle and finally they will evaluate the baseline variables as predictors of reverse LV remodeling defined by reduction of left ventricle end-diastolic and end-systolic volume at one-year follow up.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • patients with EF more than 15% and below 45%
  • Heart failure symptoms with NYHA class >2
  • Moderate-to-severe and severe functional Mitral regurgitation
Exclusion Criteria
  • degenerative mitral regurgitation
  • asymptomatic patients
  • NYHA class IV patients not able to perform 6MWT
  • EF>45%
  • poor echocardiographic acoustic window patients

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Control groupspeckle tracking analysis of transthoracic echocardiogrampatients with heart failure and concomitant severe functional mitral regurgitation that were treated with optimal medical treatment
Device groupspeckle tracking analysis of transthoracic echocardiogrampatients with heart failure and concomitant severe functional mitral regurgitation that were treated with MitraClip
Primary Outcome Measures
NameTimeMethod
Changes of LV volumesone year

change of left ventricular end-diastolic and end-systolic volumes during one-year follow up of the patients

Changes of NYHA class statusone year

measurement of NYHA class status at baseline and one-year follow uo

Secondary Outcome Measures
NameTimeMethod
Changes of myocardial work of the LVone year

Evaluation of the components of myocardial work (Global work index, global constructive work, Global wasted Work and Global Work efficiency) at baseline and one-year follow up

Trial Locations

Locations (1)

Attikon University Hospital of Athens

🇬🇷

Athens, Greece

© Copyright 2025. All Rights Reserved by MedPath